Angelalign Technology Inc. (6699) AI Stock Analysis

• Market Cap: HK$12.12B
• Dividend Yield: N/A
• Average Volume (3M): 742.42K
• Price to Earnings (P/E): 41.5
• Beta (1Y): 0.95
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: HK
• Employees: 3,576
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.70
• Shares Outstanding: 170,772,630
• 10 Day Avg. Volume: 518,175
• 30 Day Avg. Volume: 742,423
• PEG Ratio: 1.65
• Price to Book (P/B): 2.77
• Price to Sales (P/S): 4.88
• P/FCF Ratio: -124.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$75.00
• Price Target Upside: 23.15% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.16
• Revenue Forecast (FY): HK$401.21M

• Rating: 56 Neutral
• Price Target: HK$72.00 ▲(18.23% Upside)
• Action: Reiterated Date: 11/28/25
• Date: Action: Reiterated 11/28/25

Angelalign Technology Inc. has a stable financial position with strong revenue growth and low leverage, but faces challenges with profitability and cash flow management. The technical indicators suggest bearish momentum, and the high P/E ratio indicates overvaluation. These factors contribute to a moderate overall stock score.

Positive Factors

High gross margins

A gross margin above 60% indicates durable production efficiency and pricing power in aligner manufacturing. That margin cushion supports investment in tooling, R&D and scaling of production while absorbing cost inflation, helping sustain core profitability over months.

Very low leverage

Extremely low debt provides significant financial flexibility and low default risk. This capital structure allows the company to fund capex, absorb cyclical demand swings, and pursue strategic initiatives without immediate refinancing pressure, a durable balance-sheet advantage.

Platform business model with recurring case flow

Revenue tied to patient treatment cases plus digital services creates repeatable, clinic-anchored demand and potential stickiness from integrated workflows. Combined with 7.08% TTM revenue growth, the model supports steady case volume expansion and long-term service revenue attachment.

Negative Factors

Low net margin and negative EBIT

Despite strong gross margins, low net margin and negative EBIT point to persistent operating inefficiencies or elevated SG&A/R&D costs. This undermines sustainable profitability and limits internal funding for growth unless operating leverage is meaningfully improved.

Weak cash conversion

A 0.13 OCF/NI ratio and negative FCF/NI indicate earnings are not converting reliably into cash, suggesting working capital pressure or timing mismatches. This raises funding risk for growth initiatives and weakens the durability of cash generation despite headline FCF growth.

Modest return on equity

An ROE below 5% signals limited efficiency in turning shareholder capital into profits. Over multiple quarters this can constrain shareholder value creation versus peers, making it harder to justify reinvestment unless ROE improves through margin expansion or higher asset turnover.

Angelalign Technology Inc. Business Overview & Revenue Model

Company Description

Angelalign Technology Inc., an investment holding company, engages in the research and development, manufacture, and marketing of clear aligner treatment solutions in China. Its products include Angel Aligner Pro and Angel Aligner Classic, which are custom made removable clear orthodontic aligners that move the patient's teeth into the proper position over time. The company also provides orthodontics and cosmetic dentistry services, and other dental services through its dental clinics, as well as sells intraoral scanners. It markets four lines of clear aligners, including Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. The company was founded in 2003 and is headquartered in Shanghai, China.

How the Company Makes Money

Angelalign Technology Inc. generates revenue primarily through the sale of its clear aligner products to dental practitioners and clinics. The company employs a business model that includes direct sales of aligners, as well as associated services such as treatment planning and consultation. Additional revenue streams may include partnerships with dental practices and orthodontic professionals, licensing agreements for proprietary technology, and potential expansions into related dental products or services. The company's advanced digital platform is also a significant factor in driving sales, as it enhances the customer experience and streamlines the treatment process, fostering customer loyalty and repeat business.

Angelalign Technology Inc. Financial Statement Overview

Summary

Angelalign Technology Inc. shows moderate revenue growth and strong gross profit margins, indicating efficient cost management. However, low net profit margins and negative EBIT margins suggest operational inefficiencies. The balance sheet is strong with low leverage, but cash flow conversion ratios need improvement.

Income Statement

Angelalign Technology Inc. shows a moderate revenue growth rate of 7.08% TTM, indicating a positive trajectory. The gross profit margin remains strong at 62.59%, reflecting efficient cost management. However, the net profit margin is relatively low at 4.51%, suggesting room for improvement in profitability. The EBIT margin is negative, highlighting potential operational inefficiencies.

Balance Sheet

The company maintains a very low debt-to-equity ratio of 0.004, indicating strong financial stability and low leverage risk. The return on equity is modest at 4.98%, suggesting moderate efficiency in generating returns from equity. The equity ratio is healthy, showcasing a solid capital structure.

Cash Flow

Angelalign Technology Inc. exhibits a significant free cash flow growth rate of 264.85% TTM, indicating strong cash generation capabilities. However, the operating cash flow to net income ratio is relatively low at 0.13, suggesting potential challenges in converting income into cash. The negative free cash flow to net income ratio highlights potential cash flow management issues.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.23B	1.96B	1.48B	1.27B	1.27B	816.53M
Gross Profit	1.39B	1.23B	920.71M	785.69M	826.65M	575.05M
EBITDA	177.56M	77.34M	154.39M	318.65M	372.47M	224.51M
Net Income	169.84M	88.42M	53.48M	213.78M	285.85M	150.69M
Balance Sheet
Total Assets	5.59B	4.95B	4.76B	4.49B	4.14B	1.21B
Cash, Cash Equivalents and Short-Term Investments	3.49B	436.83M	3.44B	3.65B	3.63B	877.58M
Total Debt	651.66M	14.48M	65.28M	28.20M	30.29M	20.11M
Total Liabilities	2.14B	1.44B	1.35B	884.01M	826.11M	712.47M
Stockholders Equity	3.41B	3.46B	3.34B	3.61B	3.32B	501.70M
Cash Flow
Free Cash Flow	166.46M	-76.78M	51.28M	51.48M	241.95M	366.61M
Operating Cash Flow	376.79M	123.48M	165.87M	146.87M	441.71M	408.28M
Investing Cash Flow	-439.06M	-138.82M	-981.71M	-159.77M	-182.05M	-7.28M
Financing Cash Flow	-34.78M	-28.46M	-187.06M	-193.61M	2.52B	-23.33M

Angelalign Technology Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 60.90
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6699, the sentiment is Neutral. The current price of 60.9 is below the 20-day moving average (MA) of 73.86, below the 50-day MA of 69.14, and below the 200-day MA of 63.51, indicating a neutral trend. The MACD of 0.28 indicates Positive momentum. The RSI at 40.56 is Neutral, neither overbought nor oversold. The STOCH value of 11.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:6699.

Angelalign Technology Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3600	74 Outperform	HK$5.25B	3.51	16.76%	3.65%	6.87%	18.37%
2276	72 Outperform	HK$29.76B	14.57	24.01%	0.63%	13.58%	24.59%
1501	70 Neutral	HK$6.33B	10.07	10.31%	―	14.06%	3.02%
1066	68 Neutral	HK$22.52B	6.33	8.34%	4.58%	0.74%	2.13%
6699	56 Neutral	HK$12.12B	41.51	―	―	―	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Angelalign Technology Inc. Corporate Events

Angelalign Technology Inc. Revamps Share Option Scheme to Align Incentives

Angelalign Technology Inc. announced the cancellation of 1,471,435 unvested share options and the re-granting of 1,122,013 new options to key personnel, including executive directors and other employees. This strategic move aims to align the interests of key contributors with shareholders, reinforcing the company’s commitment to a performance-driven culture and optimizing its long-term talent strategy.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$74.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.